SAMRAT PHARMACHEM
|
SAMRAT PHARMACHEM Last 5 Year Balance Sheet History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹3.09 Cr | ₹3.09 Cr | ₹3.09 Cr | ₹3.09 Cr | ₹3.09 Cr |
Equity - Authorised | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr |
Equity - Issued | ₹3.09 Cr | ₹3.09 Cr | ₹3.09 Cr | ₹3.09 Cr | ₹3.09 Cr |
Equity Paid Up | ₹3.09 Cr | ₹3.09 Cr | ₹3.09 Cr | ₹3.09 Cr | ₹3.09 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹62 Cr | ₹60 Cr | ₹44 Cr | ₹27 Cr | ₹21 Cr |
Securities Premium | - | - | - | - | - |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹62 Cr | ₹60 Cr | ₹44 Cr | ₹27 Cr | ₹21 Cr |
General Reserves | - | - | - | - | - |
Other Reserves | - | - | - | - | - |
Reserve excluding Revaluation Reserve | ₹62 Cr | ₹60 Cr | ₹44 Cr | ₹27 Cr | ₹21 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹65 Cr | ₹63 Cr | ₹47 Cr | ₹30 Cr | ₹24 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | - | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹0.34 Cr | ₹0.25 Cr | ₹0.46 Cr | ₹0.43 Cr | ₹0.15 Cr |
Deferred Tax Assets | ₹0.44 Cr | ₹0.43 Cr | ₹0.14 Cr | ₹0.10 Cr | ₹0.33 Cr |
Deferred Tax Liability | ₹0.78 Cr | ₹0.68 Cr | ₹0.60 Cr | ₹0.53 Cr | ₹0.47 Cr |
Other Long Term Liabilities | - | - | - | - | - |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | - | - | - | - | - |
Total Non-Current Liabilities | ₹0.34 Cr | ₹0.25 Cr | ₹0.46 Cr | ₹0.43 Cr | ₹0.15 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹48 Cr | ₹32 Cr | ₹23 Cr | ₹18 Cr | ₹23 Cr |
Sundry Creditors | ₹48 Cr | ₹32 Cr | ₹23 Cr | ₹18 Cr | ₹23 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹0.28 Cr | ₹0.52 Cr | ₹0.89 Cr | ₹0.17 Cr | ₹0.44 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹0.10 Cr | ₹0.44 Cr | - | - | - |
Interest Accrued But Not Due | - | - | - | - | ₹0.00 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹0.18 Cr | ₹0.08 Cr | ₹0.89 Cr | ₹0.17 Cr | ₹0.44 Cr |
Short Term Borrowings | ₹8.46 Cr | ₹19 Cr | ₹7.52 Cr | ₹8.79 Cr | ₹9.10 Cr |
Secured ST Loans repayable on Demands | ₹8.46 Cr | ₹19 Cr | ₹7.52 Cr | ₹8.79 Cr | ₹9.10 Cr |
Working Capital Loans- Sec | ₹8.46 Cr | ₹19 Cr | ₹7.52 Cr | ₹8.79 Cr | ₹9.10 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-8.46 Cr | ₹-19 Cr | ₹-7.52 Cr | ₹-8.79 Cr | ₹-9.10 Cr |
Short Term Provisions | - | ₹2.14 Cr | ₹5.53 Cr | ₹0.70 Cr | ₹1.22 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | - | ₹2.14 Cr | ₹5.53 Cr | ₹0.68 Cr | ₹1.21 Cr |
Provision for post retirement benefits | - | - | - | ₹0.01 Cr | ₹0.01 Cr |
Preference Dividend | - | - | - | - | - |
Other Provisions | - | - | - | ₹0.02 Cr | - |
Total Current Liabilities | ₹56 Cr | ₹53 Cr | ₹37 Cr | ₹27 Cr | ₹34 Cr |
Total Liabilities | ₹122 Cr | ₹117 Cr | ₹85 Cr | ₹57 Cr | ₹58 Cr |
ASSETS | |||||
Gross Block | ₹17 Cr | ₹16 Cr | ₹15 Cr | ₹14 Cr | ₹11 Cr |
Less: Accumulated Depreciation | ₹5.89 Cr | ₹5.55 Cr | ₹4.91 Cr | ₹4.60 Cr | ₹4.25 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹11 Cr | ₹11 Cr | ₹9.99 Cr | ₹9.40 Cr | ₹7.19 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | - | - | - | - | ₹1.08 Cr |
Non Current Investments | ₹2.92 Cr | ₹1.86 Cr | - | - | - |
Long Term Investment | ₹2.92 Cr | ₹1.86 Cr | - | - | - |
Quoted | ₹2.92 Cr | ₹1.86 Cr | - | - | - |
Unquoted | - | - | - | - | - |
Long Term Loans & Advances | ₹1.47 Cr | ₹0.91 Cr | ₹0.80 Cr | ₹0.65 Cr | ₹0.40 Cr |
Other Non Current Assets | ₹4.06 Cr | ₹4.06 Cr | ₹2.56 Cr | ₹0.02 Cr | - |
Total Non-Current Assets | ₹19 Cr | ₹18 Cr | ₹13 Cr | ₹10 Cr | ₹8.67 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.00 Cr | ₹0.00 Cr |
Quoted | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.00 Cr | ₹0.00 Cr |
Unquoted | - | - | - | - | - |
Inventories | ₹21 Cr | ₹33 Cr | ₹12 Cr | ₹11 Cr | ₹19 Cr |
Raw Materials | ₹6.25 Cr | ₹13 Cr | ₹3.28 Cr | ₹2.57 Cr | ₹7.77 Cr |
Work-in Progress | ₹0.43 Cr | ₹0.87 Cr | ₹0.17 Cr | ₹0.08 Cr | ₹0.09 Cr |
Finished Goods | ₹14 Cr | ₹18 Cr | ₹8.90 Cr | ₹8.65 Cr | ₹11 Cr |
Packing Materials | ₹0.07 Cr | ₹0.10 Cr | ₹0.08 Cr | ₹0.10 Cr | ₹0.04 Cr |
Stores  and Spare | - | - | - | - | - |
Other Inventory | - | - | - | - | - |
Sundry Debtors | ₹69 Cr | ₹52 Cr | ₹44 Cr | ₹33 Cr | ₹28 Cr |
Debtors more than Six months | ₹1.42 Cr | ₹0.19 Cr | ₹0.10 Cr | ₹0.02 Cr | - |
Debtors Others | ₹68 Cr | ₹52 Cr | ₹44 Cr | ₹33 Cr | ₹28 Cr |
Cash and Bank | ₹9.73 Cr | ₹12 Cr | ₹15 Cr | ₹2.51 Cr | ₹1.17 Cr |
Cash in hand | ₹0.05 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.04 Cr |
Balances at Bank | ₹9.68 Cr | ₹12 Cr | ₹15 Cr | ₹2.47 Cr | ₹1.13 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹0.07 Cr | ₹0.06 Cr | ₹0.07 Cr | ₹0.38 Cr | ₹0.83 Cr |
Interest accrued on Investments | ₹0.02 Cr | ₹0.02 Cr | ₹0.03 Cr | ₹0.02 Cr | ₹0.01 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹0.05 Cr | ₹0.04 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.12 Cr |
Other current_assets | ₹0.01 Cr | ₹0.01 Cr | ₹0.02 Cr | ₹0.33 Cr | ₹0.69 Cr |
Short Term Loans and Advances | ₹2.80 Cr | ₹2.88 Cr | ₹0.49 Cr | ₹0.04 Cr | ₹1.10 Cr |
Advances recoverable in cash or in kind | ₹2.45 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹0.02 Cr | ₹1.08 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹0.35 Cr | ₹2.81 Cr | ₹0.42 Cr | ₹0.02 Cr | ₹0.02 Cr |
Total Current Assets | ₹103 Cr | ₹99 Cr | ₹71 Cr | ₹47 Cr | ₹50 Cr |
Net Current Assets (Including Current Investments) | ₹46 Cr | ₹46 Cr | ₹34 Cr | ₹20 Cr | ₹16 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹122 Cr | ₹117 Cr | ₹85 Cr | ₹57 Cr | ₹58 Cr |
Contingent Liabilities | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr |
Total Debt | ₹8.46 Cr | ₹19 Cr | ₹7.52 Cr | ₹8.79 Cr | ₹9.41 Cr |
Book Value | 210.37 | 204.37 | 151.54 | 95.92 | 78.66 |
Adjusted Book Value | 210.37 | 204.37 | 151.54 | 95.92 | 78.66 |
Compare Balance Sheet of peers of SAMRAT PHARMACHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAMRAT PHARMACHEM | ₹116.5 Cr | -10.8% | -15.4% | 9.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,838.0 Cr | 1% | 4.6% | 47.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,107.0 Cr | 1% | -3.2% | 59.3% | Stock Analytics | |
CIPLA | ₹120,270.0 Cr | -1.1% | -0.3% | 20.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,077.0 Cr | 2.2% | 12.1% | 21.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,553.2 Cr | -2.7% | 0.8% | 43.8% | Stock Analytics |
SAMRAT PHARMACHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAMRAT PHARMACHEM | -10.8% |
-15.4% |
9.8% |
SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses